In partnership with Naturegene Corp., its long-term exclusive distributor in China, IMSTAR is proud to announce its successful entry on the Chinese market of automated cytogenetics for cancer diagnostic. The french company has been choosen for providing diagnostic labs with 380 platform from the Pathfinder technology.

“Versatility and automation are key features on the fast-growing Chinese market, therefore is IMSTAR’s patented technology the most appropriate partner for Chinese labs to meet international cutting-edge standarts” says Fran├žoise Soussaline, IMSTAR’s CEO.

Together with Naturegene Corp., IMSTAR is in strong position to extend its market shares on the Chinese diagnostic market and also to genetic toxicology for which IMSTAR provides solutions amongst the most advanced wordlwide.